Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes.
about
Interactions between CYP3A4 and Dietary PolyphenolsIn vivo and in vitro metabolites from the main diester and monoester diterpenoid alkaloids in a traditional chinese herb, the aconitum speciesInduction of P-glycoprotein expression and activity by Aconitum alkaloids: Implication for clinical drug-drug interactionsCoadministration of Pinellia ternata Can Significantly Reduce Aconitum carmichaelii to Inhibit CYP3A Activity in Rats.Studies on metabolites and metabolic pathways of bulleyaconitine A in rat liver microsomes using LC-MS(n) combined with specific inhibitors.Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications.An Efficient High-performance Liquid Chromatography Combined with Electrospray Ionization Tandem Mass Spectrometry Method to Elaborate the Changes of Components Between the Raw and Processed Radix Aconitum kusnezoffii.Towards polypharmacokinetics: pharmacokinetics of multicomponent drugs and herbal medicines using a metabolomics approach.Study on the Alkaloids in Tibetan Medicine Aconitum pendulum Busch by HPLC-MSn Combined with Column ChromatographyMonoester-Diterpene Aconitum Alkaloid Metabolism in Human Liver Microsomes: Predominant Role of CYP3A4 and CYP3A5.Hepatic metabolism: a key component of herbal drugs research.Herb-Drug Pharmacokinetic Interactions: Transport and Metabolism of Indinavir in the Presence of Selected Herbal Products.Metabolite profile analysis of aconitine in rabbit stomach after oral administration by liquid chromatography/electrospray ionization/multiple-stage tandem mass spectrometry.Comparative metabolism of tussilagone in rat and human liver microsomes using ultra-high-performance liquid chromatography coupled with high-resolution LTQ-Orbitrap mass spectrometry.Comparative metabolism of four limonoids in human liver microsomes using ultra-high-performance liquid chromatography coupled with high-resolution LTQ-Orbitrap mass spectrometry.A conscious rat model involving bradycardia and hypotension after oral administration: a toxicokinetical study of aconitine.Relationships between the Toxicities of Radix Aconiti Lateralis Preparata (Fuzi) and the Toxicokinetics of Its Main Diester-Diterpenoid Alkaloids
P2860
Q26800893-2A9401AD-9419-4EF0-8A71-5E6C35E438D4Q28080742-B7E2D6EE-540D-4848-97EB-E9AD2F36379DQ28833675-0A467D39-2E66-4DC0-A10C-F49ADDF92BEDQ34412663-7A7EC1A6-4CCE-4E1D-9753-4E2D4604C98BQ35450460-42C77E73-CF6E-410A-B863-3D1ACF17DEF2Q35646205-F8411BC7-15D2-464D-911E-1437E2E81034Q36676129-6580FA3C-48A4-4C89-97F0-1A47C7B1E733Q36729102-CCC4314A-3408-4262-A2F1-EEC9FD8B92DFQ36960512-CBAFC51F-69EA-4E72-9B03-76934D654055Q36995721-CCDB075E-81AF-43FC-8550-4AA93A7DCD4FQ38258151-A3A9281D-210D-47C9-B690-A275D16FFAC1Q38810007-0A12D5E9-7136-43BF-84CB-D73E846A571FQ45285150-0FD18741-64D7-4D56-8B62-653E9C1364BBQ46654488-4D9F01CC-8086-4D8A-8236-63B7328692FBQ46658466-40BDBD9A-7BA3-455E-9053-D19D1A4036ADQ53061701-5D2A7DCE-6326-4606-846D-17A0261439E5Q58694075-A29B791C-DB6E-432F-908D-32570EDBEF51
P2860
Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@ast
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@en
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@nl
type
label
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@ast
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@en
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@nl
prefLabel
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@ast
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@en
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@nl
P2093
P1433
P1476
Involvement of CYP3A4/5 and CY ...... nd recombinant CYP450 enzymes.
@en
P2093
P356
10.1016/J.TOXLET.2011.01.019
P577
2011-01-28T00:00:00Z